| Literature DB >> 35342469 |
E Demet Akbaş1, Ö Özalp Yüreğir2, Ö Anlaş2, Z Özçelik3, O Zerrin Tolunay1.
Abstract
Triple A syndrome is an autosomal recessive inherited multisystem disorder that was first described in 1978. Triple A syndrome has a high genotypic and phenotypic heterogeneity and has been linked with mutations in the AAAS gene, which has been identified on chromosome 12q13. A 14 years old male patient applied to outpatient clinic complaining of weakness and darkening of skin color since 4 months. On physical examination hyperpigmentation was observed on both the skin and mucosa. The morning cortisol level was 1.8 μg/dL and ACTH was >1250 ng/L. Schirmer test showed absence of tears. In the patient's esophagoscopy, mucosal paleness and stenosis of the cardia were observed. Molecular genetic analysis of AAAS gene confirmed the diagnosis of triple A syndrome caused by homozygous mutation: c.1368_1372delGCTCA (p.Gln456HisfsTer38). This variant is considered to be a possible pathogenic because it causes a frame shift that changes the protein structure. As a result of the genetic analysis of the patient's parents, the AAAS gene was detected as heterozygous in both parents for the c.1368_1372delGCTCA mutation. To the best of our knowledge, this is the first report of homozygous mutation: c.1368_1372delGCTCA (p.Gln456HisfsTer38). ©2021 Acta Endocrinologica (Buc).Entities:
Keywords: AAAs gene; Novel mutation; Triple A Syndrome
Year: 2021 PMID: 35342469 PMCID: PMC8919478 DOI: 10.4183/aeb.2021.399
Source DB: PubMed Journal: Acta Endocrinol (Buchar) ISSN: 1841-0987 Impact factor: 0.877